Pulmonary Sleep Disorders Study Notes
Overview of Pulmonary Sleep Disorders
Focus of the discussion: Types of pulmonary sleep disorders, diagnosis, and treatment.
Introduction to key terms:
Obstructive Sleep Apnea (OSA)
Obesity Hypoventilation Syndrome (OHS)
Central Sleep Apnea
Types of Pulmonary Sleep Disorders
Obstructive Sleep Apnea (OSA)
Definition: A condition in which patients experience apneic events (periods of not breathing) during sleep due to airway obstruction.
Characteristics of OSA:
Obstruction can occur in different anatomic locations:
Nasal Airway Obstruction:
Possible causes include:
Deviated septum: Narrows one side of nasal cavity.
Enlarged tonsils, uvula, or soft palate: Can obstruct airflow in the nasopharynx.
Oral Pharynx Obstruction:
Commonly caused by muscle relaxation (medications, alcohol, benzodiazepines), leading to backward sagging of the tongue and other pharyngeal muscles.
Cervical Obstruction:
Patients with a very large neck size (often associated with obesity) may experience airway obstruction due to neck tissues compressing the airway during sleep.
Central Sleep Apnea
Less common than OSA.
Definition: Characterized by a cessation of breathing during sleep due to suppression of the central drive to breathe.
Mechanisms Leading to Alveolar Hypoventilation in OSA
Effects of Airway Obstruction
Implications:
Results in impaired ventilation which leads to:
Hypoxemia: Low levels of oxygen in the blood.
Hypercapnia: Elevated levels of carbon dioxide in the blood.
Key point: These effects are primarily nocturnal. Patients often experience daytime symptoms due to poor quality sleep.
Clinical consequence: Daytime somnolence, increased risk of accidents, decreased productivity, possibly headaches.
Diagnosing Pulmonary Sleep Disorders
Polysomnography
A sleep test that monitors various physiological parameters during sleep.
Key assessments include:
Breathing patterns (apnea events)
Oxygen saturation levels
Calculation of Apnea-Hypopnea Index (AHI):
Mild OSA: 5 to 14 events
Moderate OSA: 15 to 29 events
Severe OSA: 30 or more events
Arterial Blood Gas (ABG)
Assessment during daytime may reveal:
Elevated $P_{CO2} > 45$ mmHg, especially in patients with a BMI > 30, indicating OHS.
Treatment of Pulmonary Sleep Disorders
Continuous Positive Airway Pressure (CPAP)
Primary treatment for OSA.
Mechanism: Keeps the airway open by providing continuous positive pressure during sleep.
Bilevel Positive Airway Pressure (BiPAP)
Preferred for OHS, especially in cases of acute respiratory failure.
Mechanism: Delivers different pressure levels for inhalation and exhalation, aiding in ventilation.
Weight Management and Surgical Options
Treatment of the underlying cause of obesity.
Options include:
Weight loss programs
Bariatric surgery
Surgical options for airway obstruction (e.g., Uvulopalatopharyngoplasty (UPPP)).
Hypoglossal Nerve Stimulation
Surgical approach for patients with obstructive sites from tongue position.
Mechanism: Stimulator activates tongue muscles to prevent airway obstruction.
Tracheostomy
Considered in severe or refractory cases when other treatments fail.
Complications Associated with OSA and OHS
Secondary Hypertension
Caused by hypoxemia stimulating the sympathetic nervous system:
Increased systemic vascular resistance leads to elevated blood pressure.
Pulmonary Hypertension
Hypoxemia leads to pulmonary vasoconstriction and increased pulmonary vascular resistance.
Possible development of right heart failure.
Atrial Fibrillation
Persistent hypoxemia can increase ectopic foci activity, leading to atrial fibrillation.
Associated risks: Acute heart failure and thromboembolic events.
Respiratory Failure
Particularly in OHS patients, who may experience chronic hypoventilation both day and night.
Symptoms may mimic other respiratory conditions (e.g., COPD).
Conclusion
Recap of key concepts related to pulmonary sleep disorders.
Importance of correct diagnosis and management for patient outcomes.